Skip to main content

Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia

Abstract

The central nervous system toxicity of high-dose cytosine arabinoside is well recognized, but the toxicity of cytosine arabinoside in the peripheral nervous system has been infrequently reported. A 49-year-old Japanese man was diagnosed with acute myeloid leukemia. After he achieved complete remission, he received high-dose cytosine arabinoside treatment (2 g/m2 twice a day for 5 days; total, 20 g/m2) as consolidation therapy. The first course of high-dose cytosine arabinoside resulted in no unusual symptoms, but on day 21 of the second course of treatment, the patient complained of numbness in his right foot. Electromyogram and nerve-conduction studies showed peripheral neuropathy in both peroneal nerves. This neuropathy was gradually resolving; however, after the patient received allogeneic bone marrow transplantation, the symptoms worsened, with the development of graft-versus-host disease, and the symptoms subsequently responded to methylprednisolone. Although the mechanisms of peripheral neuropathy are still unclear, high-dose cytosine arabinoside is a therapy that is potentially toxic to the peripheral nervous system, and auto/alloimmunity may play an important role in these mechanisms.

This is a preview of subscription content, access via your institution.

References

  1. WJ Baker GL Royer RB Weiss (1991) ArticleTitleCytarabine and neurologic toxicity J Clin Oncol 9 679–93 Occurrence Handle1648599 Occurrence Handle1:STN:280:By6B1Mvotl0%3D

    PubMed  CAS  Google Scholar 

  2. JC Byrd RK Dodge A Carroll MR Baer C Edwards J Stamberg et al. (1999) ArticleTitlePatients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered J Clin Oncol 17 3767–75 Occurrence Handle10577848 Occurrence Handle1:STN:280:DC%2BD3c%2FksVymug%3D%3D

    PubMed  CAS  Google Scholar 

  3. B Scherokman MR Filling-Katz D Tell (1985) ArticleTitleBrachial plexus neuropathy following high-dose cytarabine in acute monoblastic leukemia Cancer Treat Rep 69 1005–6 Occurrence Handle2992782 Occurrence Handle1:STN:280:BiqB1c3jsVw%3D

    PubMed  CAS  Google Scholar 

  4. BL Powell RL Capizzi ES Lyerly MR Cooper (1986) ArticleTitlePeripheral neuropathy after high-dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia J Clin Oncol 4 95–7 Occurrence Handle3001234 Occurrence Handle1:STN:280:BimD1cfgsFc%3D

    PubMed  CAS  Google Scholar 

  5. A Borgeat B DeMuralt M Stalder (1986) ArticleTitlePeripheral neuropathy associated with high-dose Ara-C therapy Cancer 58 852–4 Occurrence Handle3013396 Occurrence Handle1:STN:280:BimB2cvntVw%3D Occurrence Handle10.1002/1097-0142(19860815)58:4<852::AID-CNCR2820580408>3.0.CO;2-I

    PubMed  CAS  Article  Google Scholar 

  6. NT Johnson SW Crawford M Sargur (1987) ArticleTitleAcute acquired demyelinating polyneuropathy with respiratory failure following high-dose systemic cytosine arabinoside and marrow transplantation Bone Marrow Transplant 2 203–7 Occurrence Handle3332167 Occurrence Handle1:STN:280:BiaD3c7ktFA%3D

    PubMed  CAS  Google Scholar 

  7. TJ Nevill TJ Benstead CW McCormick OA Hayne (1989) ArticleTitleHorner's syndrome and demyelinating peripheral neuropathy caused by high-dose cytosine arabinoside Am J Hematol 32 314–5 Occurrence Handle2554727 Occurrence Handle1:STN:280:By%2BD2MzlsFQ%3D

    PubMed  CAS  Google Scholar 

  8. M Paul D Joshua N Rahme J Pollard J Ell J Gibson et al. (1991) ArticleTitleFatal peripheral neuropathy associated with axonal degeneration after high-dose cytosine arabinoside in acute leukemia Br J Haematol 79 521–3 Occurrence Handle1661126 Occurrence Handle1:STN:280:By2D1cfptlY%3D

    PubMed  CAS  Google Scholar 

  9. H Openshaw NE Slatkin AS Stein DR Hinton SJ Forman (1996) ArticleTitleAcute polyneuropathy after high dose cytosine arabinoside in patients with leukemia Cancer 78 1899–905 Occurrence Handle8909309 Occurrence Handle1:CAS:528:DyaK28XmvFylt74%3D Occurrence Handle10.1002/(SICI)1097-0142(19961101)78:9<1899::AID-CNCR9>3.0.CO;2-A

    PubMed  CAS  Article  Google Scholar 

  10. MD Winkelman JD Hines (1996) ArticleTitleCerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study Ann Neurol 14 520–7 Occurrence Handle10.1002/ana.410140505

    Article  Google Scholar 

  11. AJ Aguayo JS Romine GM Bray (1975) ArticleTitleExperimental necrosis and arrest of proliferation of Schwann cells by cytosine arabinoside J Neurocytol 4 663–74 Occurrence Handle1194930 Occurrence Handle1:CAS:528:DyaE28XlsVOktg%3D%3D Occurrence Handle10.1007/BF01181629

    PubMed  CAS  Article  Google Scholar 

  12. L Montalbetti G Brambilla Pisoni G Trotti MV Calloni (1992) ArticleTitlePolyneuritis after HD Ara-C therapy for malignant lymphoma Ital J Neurol 13 85 Occurrence Handle1:STN:280:By2B3MfhsFY%3D Occurrence Handle10.1007/BF02222895

    CAS  Article  Google Scholar 

  13. D Machover B Delmas-Marsalet SC Misra Y Gumus E Goldschmidt A Schilf et al. (2001) ArticleTitleDexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma Ann Oncol 12 1439–43 Occurrence Handle11762817 Occurrence Handle1:STN:280:DC%2BD38%2FjsFakug%3D%3D Occurrence Handle10.1023/A:1012501305214

    PubMed  CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takeshi Saito.

About this article

Cite this article

Saito, T., Asai, O., Dobashi, N. et al. Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia. J Infect Chemother 12, 148–151 (2006). https://doi.org/10.1007/s10156-006-0443-1

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-006-0443-1

Key words

  • Peripheral neuropathy
  • Cytosine arabinoside
  • Ara-C
  • Side effect
  • Acute myeloid leukemia